Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cordis Stresses Durability Of Fortron AAA System, European Safety Results

This article was originally published in The Gray Sheet

Executive Summary

The positive safety profile of Johnson & Johnson/ Cordis' Fortron abdominal aortic aneurysm (AAA) stent graft, as demonstrated in Europe, likely will be a key component of the firm's U.S. marketing strategy
Advertisement

Related Content

Guidant Likely Will Bow Out Of AAA Race As Stakes Rise Too High
Medtronic Talent Stent Graft Draws MDA Alert; Firm Eyes 2003 U.S. Launch
J&J/Cordis Teramed Alliance Suggests Swifter Access To $1 Bil. AAA Market
J&J/Cordis Teramed Alliance Suggests Swifter Access To $1 Bil. AAA Market
Advertisement
UsernamePublicRestriction

Register

MT018537

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel